Status:
COMPLETED
Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma
Lead Sponsor:
University Hospital Muenster
Collaborating Sponsors:
Nichols Institute Diagnostika GmbH, Bad Vilbel, Germany
Conditions:
Thyroid Neoplasms
Eligibility:
All Genders
Brief Summary
Human thyroglobulin (Tg) is the most sensitive biochemical marker for recurrence of differentiated cancer (DTC), especially after the complete removal of thyroid tissue through surgery and radioiodine...
Detailed Description
Sera of 100 consecutive DTC patients after total thyroidectomy were to be collected at the Department of Nuclear Medicine both under TSH-suppression therapy and under endogenous TSH stimulation (TSH \...
Eligibility Criteria
Inclusion
- histological diagnosis of differentiated thyroid carcinoma
- total or near total thyroidectomy
- informed consent
Exclusion
- no informed consent
Key Trial Info
Start Date :
September 1 2003
Trial Type :
OBSERVATIONAL
End Date :
June 1 2005
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00148213
Start Date
September 1 2003
End Date
June 1 2005
Last Update
September 7 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Nuclear Medicine, Münster University Hospital
Münster, Germany, 48129